hexamethonium has been researched along with Adjuvant Arthritis in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanashiro, A | 1 |
| Talbot, J | 1 |
| Peres, RS | 1 |
| Pinto, LG | 1 |
| Bassi, GS | 1 |
| Cunha, TM | 1 |
| Cunha, FQ | 1 |
1 other study available for hexamethonium and Adjuvant Arthritis
| Article | Year |
|---|---|
Neutrophil Recruitment and Articular Hyperalgesia in Antigen-Induced Arthritis are Modulated by the Cholinergic Anti-Inflammatory Pathway.
Topics: Animals; Antigens; Arthritis, Experimental; Arthritis, Rheumatoid; Atropine Derivatives; Cholinergic | 2016 |